Company: RNGE
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001343
Chunk: 179

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 179
---

    First Quarter ended March 31, 2023 
    $0.20  
    $0.15 
  
    Second Quarter ended June 30, 2023 
     0.20  
     0.15 
  
    Third Quarter ended September 30, 2023 
     0.20  
     0.10 
  
    Fourth Quarter ended December 31, 2023 
     0.37  
     0.12 

    Fiscal Year Ended December 31, 2024 

    First Quarter ended March 31, 2024 
    $0.41  
    $0.37 
  
    Second Quarter ended June 30, 2024 
     0.37  
     0.36 
  
    Third Quarter ended September 30, 2024 
     0.32  
     0.26 
  
    Fourth Quarter ended December 31, 2024 
     0.21  
     0.18 

Transfer
Agent

The
transfer agent and registrar for our common stock is Securities Transfer Corporation, 2901 North Dallas Parkway, Suite 380, Plano, Texas
75093.

Holders
of Common Stock

As
of March 28, 2025, there were 72 holders of record of our common stock.

Dividends

We
have never declared or paid any cash dividends or distributions on our common stock. We currently intend to retain our future earnings,
if any, to support operations and to finance expansion, and we do not anticipate paying any cash dividends on our common stock in the
foreseeable future.

Equity
Compensation Plan Information

During
the year ended December 31, 2024, we issued options to purchase 250,000 shares of the Company’s common stock under the Range Impact,
Inc. 2021 Stock Incentive Plan. Except as listed in the table below, as of December 31, 2024, we do not have any equity-based plans,
including individual compensation arrangements, which have not been approved by our stockholders.

24

The
following table provides information as of December 31, 2024 with respect to our equity compensation plans:

Equity
Compensation Plan Information

    Plan Category 
    Number
                                            of securities
                                            to be issued
                                            upon exercise
                                            of outstanding options,
                                            warrants and
                                            rights